David O Walterhouse

  • 2139 Citations
1984 …2017

Personal profile

Certifications and Licenses

1986Residency, Children's Hospital of Philadelphia
1989Fellowship, Children's Hospital of Philadelphia
Pediatrics
Pediatric Hematology-Oncology

Certifications and Licenses

1986Residency, Children's Hospital of Philadelphia
1989Fellowship, Children's Hospital of Philadelphia
Pediatric Hematology-Oncology
Pediatrics

Education / Academic qualification

MD, University of Michigan

… → 1983

Keywords

  • Pediatrics
  • Clinical Research
  • Signal Transduction
  • Developmental biology
  • Oncology
  • Cancer Biology

Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Rhabdomyosarcoma Medicine & Life Sciences
Hedgehogs Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Vincristine Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2017

1 Citations

45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Ermoian, R. P., Breneman, J., Walterhouse, D. O., Chi, Y. Y., Meza, J., Anderson, J., Hawkins, D. S., Hayes-Jordan, A. A., Parham, D. M., Yock, T. I., Donaldson, S. S. & Wolden, S. L. Sep 1 2017 In : Pediatric Blood and Cancer. 64, 9, e26540

Research output: Contribution to journalArticle

Embryonal Rhabdomyosarcoma
Sarcoma
Radiotherapy
Drug Therapy
Rhabdomyosarcoma
3 Citations

Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Walterhouse, D. O., Pappo, A. S., Meza, J. L., Breneman, J. C., Hayes-Jordan, A., Parham, D. M., Cripe, T. P., Anderson, J. R., Meyer, W. H. & Hawkins, D. S. Jun 15 2017 In : Cancer. 123, 12, p. 2368-2375 8 p.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Sarcoma
Cyclophosphamide
Recurrence
Embryonal Rhabdomyosarcoma
4 Citations

Sonic hedgehog regulation of Foxf2 promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis

Everson, J. L., Fink, D. M., Yoon, J. W., Leslie, E. J., Kietzman, H. W., Ansen-Wilson, L. J., Chung, H. M., Walterhouse, D. O., Marazita, M. L. & Lipinski, R. J. Jan 1 2017 In : Development (Cambridge). 144, 11, p. 2082-2091 10 p.

Research output: Contribution to journalArticle

Hedgehogs
Neural Crest
Cleft Lip
Mesoderm
Lip
5 Citations

Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group

Arnold, M. A., Anderson, J. R., Gastier-Foster, J. M., Barr, F. G., Skapek, S. X., Hawkins, D. S., Raney, R. B., Parham, D. M., Teot, L. A., Rudzinski, E. R. & Walterhouse, D. O. Apr 1 2016 In : Pediatric blood & cancer. 63, 4, p. 634-639 6 p.

Research output: Contribution to journalArticle

Alveolar Rhabdomyosarcoma
Histology
Embryonal Rhabdomyosarcoma
Rhabdomyosarcoma
Orbit
Adjuvant Chemoradiotherapy
Rhabdomyosarcoma
Cardiopulmonary Bypass